BREAKING NEWS
Source: U.S. Medical News  Mar 26, 2022  2 months ago
U.S. CDC Data Reveals That Those Who Received Only Johnson & Johnson Shots More Likely To Die During Omicron Wave Compared To Other Shots!
2636 Shares
facebook sharing button Share
twitter sharing button Tweet
linkedin sharing button Share
U.S. CDC Data Reveals That Those Who Received Only Johnson & Johnson Shots More Likely To Die During Omicron Wave Compared To Other Shots!
Source: U.S. Medical News  Mar 26, 2022  2 months ago
U.S. Medical News: According to data from the U.S. U.S. Centers for Disease Control and Prevention or CDC, the COVID-related death rate among Americans who received Johnson & Johnson's COVID-19 vaccine was more than double that of people who received other vaccines! https://covid.cdc.gov/covid-data-tracker/#rates-by-vaccine-status


 
It was reported that for the week of Jan. 8, as cases of the highly contagious variant surged, the rate of COVID-related deaths among Americans who had the Johnson & Johnson (J&J) shot was more than five in 100,000 as per the figures from the U.S. Centers for Disease Control and Prevention.
 
This was compared with about two deaths per 100,000 among those who received the Pfizer or Moderna mRNA vaccines, CBS News reported. https://www.cbsnews.com/news/covid-omicron-johnson-johnson-vaccine/
 
However, the death rates among those with the J&J shot which is not an mRNA vaccine were still much lower than those among unvaccinated Americans.
 
For the unvaccinated according to the U.S. CDC data, their death rate was close to 20 per 100,000.
 
Interestingly, it was also found that among individuals who received booster shots, those initially vaccinated with the J&J vaccine had higher COVID-19 death rates than those who started with doses of Pfizer or Moderna.
 
Breakthrough infections however among J&J vaccine recipients were similar or lower compared to the others, according to CDC data released as federal officials consider a new round of booster shots.
 
Shockingly J&J spokesman Jake Sargent responded in a written statement, "The CDC data adds to the growing body of evidence indicating the Johnson & Johnson COVID-19 vaccine provides durable protection against breakthrough infection and hospitalization.”
 
The U.S. CDC data were not adjusted for a number of factors that can affect direct comparisons between different groups of vaccinated individuals, including length of time since vaccination and underlying health problems.
 
Dr Dan Barouch, director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center in Boston, told U.S. Medical News, "The J&J vaccine is different in that, initially the antibody responses are quite a bit lower than the mRNA vaccines. But those responses actually are maintained very well over time, even increase a little bit."
 
Currently in the United States, only immunocompromised recipients of the J&J shot are eligible to receive a third shot. But that could change soon. Both Moderna and Pfizer-BioNTech are seeking to roll out additional booster shots that would include recipients of the Johnson & Johnson vaccine.
 
It was reported that the U.S. Food and Drug Administration (FDA) plans to discuss additional boosters next month.
 
However, it was also reported that America is currently facing a shortage of capital to fund furthe r testing, treatments, vaccines and drugs to fight the ever continuing COVID-19 pandemic.
 
The American healthcare sector is also facing stress and a threat from mounting Long COVID patients that are developing a wide spectrum of health conditions and medical anomalies. The current administration is trying hard to conceal or not recognize the many serious long-term effects of SARS-CoV-2 infections including aggressive accelerated cancers, fatal CVST, heart failures, strokes, organ failures, immunodeficiency conditions and secondary pathogenic infections etc.
 
The infamous Dr Anthony Fauci who is also the U.S. President's chief medical advisor, told media in January, "Given the parallel protection that we have seen with J&J that is boosted or the mRNAs that are boosted, as well as the mix and match, which have been done, where you can vaccinate with one platform and boost with the other, we have found very interestingly that it works quite well!"
 
Thailand Medical News envisages that in coming weeks and months, we should have even more funny revelations from the US.CDC and other American health agencies like the U.S. NIH and also the U.S.FDA.
 
For more on the hilarious American Approach To the COVID-19 Pandemic, keep on logging to Thailand Medical News.
 

MOST READ

Aug 13, 2020  2 years ago
Source: Supplements For COVID-19
Feb 05, 2020  2 years ago
Source : Thailand Medical news